Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 29 May 2026 for Edesa Biotech, Inc..
Filing timeline
BuySaleCarlo Sistilli
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +43.1%Entry US$24.22 · Close at T+365 US$34.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Carlo Sistilli: trading record in brief
All filings by Carlo Sistilli on record concern Edesa Biotech, Inc. In total, 6 filings cover trades dated from 8 January 2020 to 27 May 2026.
The open-market record is one-sided, with 1 purchase worth €8,976 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants.
The newest entry dates from 29 May 2026: a share grant, in Edesa Biotech, Inc. The latest purchase dates back some time: it was published 2,478 days ago, on 10 January 2020. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carlo Sistilli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
19,000 shares0Common SharesSEC:0001171843-26-003800:0
20,001 shares0Common SharesSEC:0001171843-25-003591:0
10,416 shares@ US$1.92100.0% of flowCommon SharesSEC:0001171843-25-000869:0
1,218 shares@ US$4.0010.0% of flowCommon sharesSEC:0001654954-20-011927:0
2,436 shares@ US$4.1127.7% of flowCommon SharesSEC:0001654954-20-000269:0
Canonical exit: 7 Apr 2020 (T+90)
5 of 5 declarations
